The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Mylan Inc.

  • MYL
  • NASDAQ
  • Consumer Products
  • Latest 47.21
  • Currency US$
  • Change 0.98
  • Percent Change 2.12 %
  • Volume 4,055,353
  • Wed Apr 16, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 46.88
  • Previous Close 46.23
  • High 47.31
  • Low 46.35
  • Bidx0 0.0000
  • Askx0 0.0000
  • 52-week High03/04 57.52
  • 52-week Low04/18 27.655
  • Beta 1.08
  • Market Cap 18,074.82M
  • EPS 1.58
  • P/E 29.88
  • Forward P/E 12.04
  • PEG 1.12
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $6,909,150,000
  • Earnings $623,710,000
  • Return on Equity 20.14%

Cash Flow

  • Cash Flow --
  • Cash $291,290,000
  • Current Ratio 1.51

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $15,236,340,000
  • Liabilities $12,276,430,000
  • Liabilities-to-Equity Ratio 4.15

Price Ratios

  • Price to Sales 2.62
  • Price to Book 6.11
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Feb 27 $0.75 May 1 $0.63
Surprises Feb 27 4.00% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 17, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

Related Securities
Symbol Type Latest % Chg

Officers

  • Robert J. Coury Executive Chairman and Directo
  • Rodney L. Piatt Vice Chairman and Director
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

1500 CORPORATE DRIVE
CANONSBURG, PA
15317

Phone: (724)-514-1800
Fax: (724)-5141870


www.mylan.com

Ideas & Discussion

Live Discussion of MYL on StockTwits